Neuroimmune biomarkers in schizophrenia
- 1 September 2016
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 176 (1) , 3-13
Abstract
No abstract availableKeywords
Funding Information
- Virgo Consortium
- Dutch government project (FES0908)
- Netherlands Genomics Initiative (NGI) project (050-060-452)
- Dutch Fund for Economic Structure Reinforcement
- NeuroBasic PharmaPhenomics project (0908)
- Marie Curie Actions Industry Academia Partnerships and Pathways (286334)
- Stanley Medical Research Institute (SMRI)
This publication has 162 references indexed in Scilit:
- Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophreniaMolecular Psychiatry, 2012
- Childhood infection and adult schizophrenia: A meta-analysis of population-based studiesSchizophrenia Research, 2012
- Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studiesPsychological Medicine, 2012
- Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial OveractivationJournal of Neuroimmune Pharmacology, 2011
- Disease-relevant autoantibodies in first episode schizophreniaJournal of Neurology, 2010
- Activation of brain interleukin-1β in schizophreniaMolecular Psychiatry, 2009
- Common variants on chromosome 6p22.1 are associated with schizophreniaNature, 2009
- Common variants conferring risk of schizophreniaNature, 2009
- Endophenotypes in schizophrenia: A selective reviewSchizophrenia Research, 2009
- Molecular Evidence for Increased Expression of Genes Related to Immune and Chaperone Function in the Prefrontal Cortex in SchizophreniaBiological Psychiatry, 2007